Alpha Teknova (TKNO) Net Cash Flow Growth (3y) (2023 - 2026)
Alpha Teknova (TKNO) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | -62.71% |
| 10 | Alpha Teknova | 257.85 Mn | 240.06 Mn | 3.78 Mn | 48.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.88% |
| Dec 31, 2025 | 33.05% |
| Sep 30, 2025 | 83.09% |
| Jun 30, 2025 | 79.50% |
| Mar 31, 2025 | 68.96% |
| Dec 31, 2024 | 38.54% |
| Sep 30, 2024 | -7.55% |
| Jun 30, 2024 | -26.66% |
| Mar 31, 2024 | -37.82% |
| Dec 31, 2023 | -153.01% |
| Sep 30, 2023 | 543.77% |